Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis.
Sotaro MoriTakuji KurimotoYusuke MuraiKaori UedaMari SakamotoNorio ChiharaYuko Yamada-NakanishiMakoto NakamuraPublished in: Journal of ophthalmology (2020)
Immunosuppressants can potentially decrease relapses and steroid dosage in patients with anti-AQP4 or MOG antibody-positive ON without severe adverse events and the exacerbation of visual acuities.